SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending as investors debate the impact of a newly announced multi-billion dollar AI infrastructure deal with Supermicro, which is being viewed as a significant validation of the company's growth strategy. While some community members highlight the potential for a massive short squeeze due to high short interest and a tight float, others remain focused on long-term execution risks and the company's capital requirements to fund such large-scale projects.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a surprise early release of strong first-quarter earnings that surpassed analyst expectations and the announcement of a new 2 billion dollar share repurchase program. The community is actively debating the impact of this buyback on the stock's short interest and debating the potential long-term strategic implications of leadership's capital allocation decisions.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is experiencing a massive, sentiment-driven rally following an enthusiastic endorsement from NVIDIA's CEO, who labeled it a potential trillion-dollar company due to its critical role in AI connectivity and data center infrastructure. While the community is split between bullish investors riding the momentum and skeptics calling for an imminent correction due to extreme valuations, the stock remains a central focus for traders betting on the continued expansion of the AI hardware trade.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing significant investor attention fueled by a $3.65 billion investment-grade financing facility to support its multi-year AI cloud contract with Microsoft. The community is actively debating the potential for a massive short squeeze as the stock hovers near critical resistance levels, with many focusing on the company's aggressive infrastructure expansion and its strategic alignment with the NVIDIA ecosystem.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is surging to 52-week highs amid intense social media buzz surrounding its pivot to physical AI and automotive software via the QNX platform. The community is aggressively discussing a potential short squeeze and long-term valuation turnaround, fueled by recent management commentary and significant spikes in after-hours trading volume.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is experiencing high volatility as investors balance strong earnings beats and raised guidance against concerns over premium valuations and acquisition-related transparency. The community is actively debating whether to hold through this momentum or lock in profits, while broader sentiment remains optimistic about the long-term role of cybersecurity in an AI-driven environment.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending following a series of significant share purchases by CEO Kevin Tang, which has sparked intense community speculation regarding a potential buyout or strategic shift. Investors are actively debating the company's future direction, expressing both anticipation for upcoming earnings and frustration over the lack of direct management communication since the leadership transition.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing intense volatility as investors debate the massive capital expenditure on AI infrastructure, with community sentiment split between those viewing the pullback as a buying opportunity and others concerned over long-term ROI. Market participants are actively discussing Meta's competitive positioning in AI versus peers, with some referencing recent endorsements from industry leaders while others highlight institutional concerns about spending levels and potential share dilution.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is trending as investors grapple with extreme volatility and rapid decay, driven by a relentless semiconductor rally fueled by record-breaking AI optimism and heavy institutional rotation into names like Broadcom and Marvell. The community is actively debating the risks of holding such a heavily leveraged inverse ETF, with many participants expressing deep frustration over consistent losses and the potential for another reverse split while others attempt to time a reversal against what they characterize as a speculative AI bubble.

LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. Its products include Protandim, Axio, TrueScience, PhysIQ, and Petandim. It operates through the Americas, and Asia or Pacific and Europe geographical segments. The company was founded in June 1988 and is headquartered in Lehi, UT.

Lifevantage Corporation

Lifevantage Corporation is gaining momentum as investors track a potential short squeeze fueled by an exceptionally high cost-to-borrow and limited share availability. The community is focused on the stock's constrained float and is actively debating whether current institutional short pressure will trigger an explosive move to the upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034)  DelveInsight

Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight Biliary Tract Cancer Market is Predicted to Exhibit...

Seattle Genetics is a clinical-stage biotechnology company that focuses on developing and commercializing monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Its lead product, SGN-35, is in the pivotal trial for patients with relapsed or refractory Hodgkin lymphoma. The company's other product candidates in various stages of clinical trials include dacetuzumab (SGN-40), a humanized anti-CD40 antibody; lintuzumab (SGN-33), a humanized anti-CD33 antibody; SGN-70, a humanized anti-CD70 antibody for the treatment of autoimmune diseases; SGN-75, which is in Phase I clinical trials for metastatic renal cell carcinoma and non-Hodgkin lymphoma; ASG-5ME, a preclinical antibody-drug conjugate product candidate for the treatment of solid tumors; and SGN-19A, a preclinical antibody-drug conjugate product candidate for the treatment of hematologic malignancies. It has collaborations with Bayer Pharmaceuticals Corporation; Celldex Therapeutics, Inc.; Daiichi Sankyo Co., Ltd.; Genentech; GlaxoSmithKline LLC; MedImmune, Inc.; Millennium; PSMA Development Company LLC; and Genmab A/S. The company also has an antibody-drug conjugates co-development agreement with Agensys, Inc.  The company was founded in 1997 and is headquartered in Bothell, Washington.

SGENSeagen Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SGEN News